A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...
Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.
Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...
Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...
A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.
Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...
Hereditary breast cancer results from inherited mutations, primarily in BRCA1 and BRCA2, increasing lifetime cancer risk. Additional genes like TP53, PTEN, PALB2, CHEK2, and ATM also contribute to ...
The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...
Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results